PFIZER INC.
- Country
- 🇺🇸United States
- Ownership
- Public
- Established
- 1849-01-01
- Employees
- 88K
- Market Cap
- $163.3B
- Website
- http://www.pfizer.com
Multiple Dose Safety Tolerability, Pharmacokinetics And Midazolam Interaction In Healthy Overweight And Obese Subjects
- Conditions
- Diabetes Mellitus Type 2
- Interventions
- First Posted Date
- 2013-03-08
- Last Posted Date
- 2013-09-17
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 15
- Registration Number
- NCT01807377
- Locations
- 🇺🇸
Pfizer Investigational Site, Chula Vista, California, United States
Study Evaluating The Safety, Tolerability And Brain Function Of 2 Doses Of PF-0254920 In Subjects With Early Huntington's Disease
- First Posted Date
- 2013-03-07
- Last Posted Date
- 2017-12-14
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 37
- Registration Number
- NCT01806896
- Locations
- 🇫🇷
Centre d'Investigation Clinique (CIC)/ Institut du Cerveau et de la Möelle Epinière (ICM), Paris Cedex 13, France
The Study Of Fluconazole For Vulvovaginal Candidiasis
- First Posted Date
- 2013-03-07
- Last Posted Date
- 2021-07-19
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 157
- Registration Number
- NCT01806623
- Locations
- 🇯🇵
Hayakawa Clinic, Osaka, Japan
🇯🇵Mori Ladies Clinic, Fukuoka, Japan
🇯🇵IZUMI Ladies' Clinic, Gifu, Japan
A Study Comparing the Plasma Drug Exposure of an Oral Dose of Palbociclib (PD-0332991) to an Intravenous Dose of Palbociclib (PD-0332991)
- Conditions
- Healthy
- Interventions
- Drug: Oral Drug Formulation of PD-0332991Drug: Intravenous Formulation of PD-0332991
- First Posted Date
- 2013-03-01
- Last Posted Date
- 2013-12-17
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 14
- Registration Number
- NCT01802476
- Locations
- 🇬🇧
Pfizer Investigational Site, NOttingham, Nottinghamshire, United Kingdom
Effect Of PF-06305591 On Capsaicin And Capsaicin/Heat-Induced Neurogenic Flare
- Conditions
- Healthy
- Interventions
- First Posted Date
- 2013-02-25
- Last Posted Date
- 2013-08-20
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 16
- Registration Number
- NCT01797796
- Locations
- 🇧🇪
Pfizer Investigational Site, Brussels, Belgium
A Study To Assess Absorption Of Study Drug Dacomitinib (PF-00299804), Given As An Oral Tablet Compared To An Intravenous Infusion In Healthy Volunteers
- Conditions
- Healthy Volunteers
- Interventions
- First Posted Date
- 2013-02-21
- Last Posted Date
- 2015-10-08
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 14
- Registration Number
- NCT01796327
- Locations
- 🇬🇧
Pfizer Investigational Site, Ruddington Fields, Nottingham, United Kingdom
Topical Ibuprofen for Delayed Onset Mulscle Soreness
- Conditions
- Pain
- Interventions
- First Posted Date
- 2013-02-20
- Last Posted Date
- 2021-09-30
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 205
- Registration Number
- NCT01794923
- Locations
- 🇺🇸
Institute for Applied Pharmaceutical Research, Philadelphia, Pennsylvania, United States
Single Dose Safety, Tolerability, Pharmacokinetics And Pharmacodynamics Study Of PF-06291874 In Healthy Adult Subjects
- First Posted Date
- 2013-02-18
- Last Posted Date
- 2013-04-04
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 8
- Registration Number
- NCT01794364
- Locations
- 🇺🇸
Pfizer Investigational Site, New Haven, Connecticut, United States
PF-04634817 Renal Impairment Study
- First Posted Date
- 2013-02-15
- Last Posted Date
- 2024-03-01
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 32
- Registration Number
- NCT01791855
- Locations
- 🇺🇸
Unversity of Miami, Miami, Florida, United States
🇺🇸Avail Clinical Research, LLC, DeLand, Florida, United States
Post Marketing Surveillance For General Drug Use To Assess the Safety And Efficacy Profile Of Viviant In Usual Practice
- First Posted Date
- 2013-02-15
- Last Posted Date
- 2018-12-24
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 3430
- Registration Number
- NCT01793142
- Locations
- 🇰🇷
Dongguk University Ilsan Hospital, Goyang-si, Gyeonggi-do, Korea, Republic of
🇰🇷Soon Chun Hyang University Hospital Seoul, Seoul, Korea, Korea, Republic of
🇰🇷Sung Mo O.S, Daebang-dong, Seoul, Korea, Republic of